Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00222937 · ClinicalTrials.gov registry record · Phase 3

Voice Therapy for Teachers With Voice Problems

A Phase 3 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 3
Development phase
105
Enrollment target

NCT00222937: Completed Phase 3 study, sponsored by University of Pittsburgh.

NCT00222937 is a Phase 3 study that has completed, run by University of Pittsburgh. The registered enrollment target is 105 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00222937, a Phase 3 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 3
Development phase
105 participants
Enrollment target

Study Summary

The study compares two different forms of voice therapy, Lessac-Madsen Resonant Voice Therapy and Casper-Based Confidential Flow Therapy. The target population are teachers because they have the highest risk for developing voice problems. For this study the investigators are primarily interested in seeing if Lessac-Madsen Resonant Voice Therapy (LMRVT) and Casper-Based Confidential Flow Therapy (CBCFT) are equally effective at improving vocal functioning in teachers with phonotrauma, as assessed by the Voice Handicap Index (VHI).

Interventions

  • BEHAVIORAL Lessac-Madsen Resonant Voice Therapy
  • BEHAVIORAL Casper-Based Confidential Flow Therapy

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2005-10
Est. Completion 2010-08
Phase Phase 3
University of Pittsburgh

1,238 total trials

What the finished NCT00222937 record still lists

NCT00222937 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Lessac-Madsen Resonant Voice Therapy is the first listed.

NCT00222937 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00222937 about?

NCT00222937 is a clinical study titled "Voice Therapy for Teachers With Voice Problems". The study compares two different forms of voice therapy, Lessac-Madsen Resonant Voice Therapy and Casper-Based Confidential Flow Therapy. The target population are teachers because they have the highest risk for developing voice problems. For this study the investigators are primarily interested in ...

What is the current status of trial NCT00222937?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 105 participants. The study started on 2005-10. Estimated completion is 2010-08.

What interventions are being tested in trial NCT00222937?

The interventions under investigation include: Lessac-Madsen Resonant Voice Therapy (BEHAVIORAL), Casper-Based Confidential Flow Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00222937?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00222937's enrollment target sits among peer trials

105 1670th of 2000 higher than 330 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00222937, the US trial registry maintained by the National Library of Medicine. NCT00222937 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.